Inventor · disambiguated record
Pilin Wang
Also filed as: WANG PILIN
4 granted patents·9 pending applications·7 citations·filing 2016–2023
63Inventor score
Top patents by PatentIndex Score
13 records- 0185US11225522B2Single domain antibody and derivative proteins thereof against programmed death-ligand (PDL1)SUZHOU ALPHAMAB CO LTD·Filed 2016·Granted Jan 18, 2022·6 cites·20 claims
- 0281US11634492B2Dimers and use thereofJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2021·Granted Apr 25, 2023·1 cites·14 claims
- 0361US12281163B2Dimers and use thereofJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Apr 22, 2025·0 cites·14 claims
- 0456US2025346645A1Fusion protein and application thereofSUZHOU ALPHAMAB CO LTD·Filed 2022·Application pending·0 cites
- 0555US2024076345A1Human glp-1 polypeptide variant and use thereofSUZHOU ALPHAMAB CO LTD·Filed 2021·Application pending·0 cites
- 0655US2024101707A1A method of preventing, alleviating or treating a tumorJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0754US2024307551A1Antibody-drug conjugate and application thereofJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0851US2024247076A1Coagulation factor xi (fxi) binding proteinSUZHOU ALPHAMAB CO LTD·Filed 2021·Application pending·0 cites
- 0950US12448450B2Method for treating tumor using anti-CTLA4 single-domain antibodiesJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 21, 2025·0 cites·10 claims
- 1049US2023151116A1Efficacious dose for her2 bispecific antibodyJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1149US2024141070A1Ox40/pd-l1 bispecific antibodyJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1245US2023017515A1COMBINATION OF BISPECIFIC FUSION PROTEIN AND ANTI-Her2 ANTIBODY FOR TUMOR TREATMENTJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1345US2023118053A1Combination of anti-her2 antibody and cdk inhibitior for tumor treatmentJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pilin Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →